Product Information File (PIF): What to Expect From the Audit? - - PowerPoint PPT Presentation

product information file pif what to expect from the
SMART_READER_LITE
LIVE PREVIEW

Product Information File (PIF): What to Expect From the Audit? - - PowerPoint PPT Presentation

Product Information File (PIF): What to Expect From the Audit? Presentation Layout Introduction PMS Programme Product Information File (PIF) PIF Audit Future Plan Introduction Cosmetic product is controlled through


slide-1
SLIDE 1

Product Information File (PIF): What to Expect From the Audit?

slide-2
SLIDE 2

Presentation Layout

 Introduction  PMS Programme  Product Information File (PIF)  PIF Audit  Future Plan

slide-3
SLIDE 3

Introduction

  • Cosmetic product is controlled through

notification procedure.

  • No pre market approval = declaration of

compliance by the CNH to the relevant Acts, Regulations, Guidelines and Directives/ Circulars.

  • Compliance is monitored by the NPCB through

PMS programme.

slide-4
SLIDE 4

PMS Programme

 Product Screening  Sample Collection/ Testing  Advertisement Monitoring  Label Checking  PIF Audit  GMP Audit  Handling of Complaint  Monitoring of Adverse Event  ASEAN Alert

slide-5
SLIDE 5

PIF : Key Points

  • PIF = Document to support the Safety, Quality

and Claimed Benefit of the marketed cosmetic products.

  • CNH to ensure that PIF is accessible for audit

at the address specified on the label within the given timeframe.

  • Language : English or Bahasa Malaysia

Reference : Guidelines for Product Information File (PIF)

slide-6
SLIDE 6

PIF : General Content

Quality

Ingredients/Raw Material :

  • Identity, concentration used and its function

(perfume : name and code number of the composition and supplier’s identity)

  • Raw material specifications and test methods
slide-7
SLIDE 7

PIF : General Content

Quality

Finish Product:

  • Manufacturing
  • Manufacturer’s details (including assembler, if any)
  • Documents to ensure that the product is manufactured

in accordance to the Guidelines for Cosmetic Good Manufacturing Practice (GMP) or its equivalent*

  • Summary of manufacturing process
  • Finish product specification and test methods
  • Stability report (mandatory for product with durability

below 30 months)

*ASEAN endorsed GMP standard

slide-8
SLIDE 8

PIF : General Content

Safety

  • Safety assessment on ingredient / raw material
  • Safety assessment on finish product based on its ingredient,

their chemical structure and level of exposure

  • Post market safety data : undesirable effects
  • Signed assessment report by the qualified safety assessor
slide-9
SLIDE 9

PIF : General Content

Claimed Benefit

Supporting data to justify the cosmetic claim made on product label or in advertisement:

  • Ingredient based and/or Formulation based approach can be

accepted to support the claim provided that it is scientifically justified.

  • There are ways to measure such claim such as:
  • Expert assessment
  • Instrumental assessment
  • Self assessment
slide-10
SLIDE 10

PIF Audit : Objective

  • To verify compliance declared by the CNH

during the notification submission.

slide-11
SLIDE 11

PIF Audit: Product Criteria

  • Whitening product
  • High risk product : used around the eye area

and baby product

  • Manufacturer /CNH with history of product

cancellation and/or recall, product that failed laboratory testing

  • Manufacturer with poor Good Manufacturing

Practice (GMP) status

slide-12
SLIDE 12

PIF Audit: Criteria

  • Other factors that triggers PIF audit:
  • Suspicious product name
  • Complaint
  • Advertisement
  • Label
slide-13
SLIDE 13

PIF Audit : Statistic

slide-14
SLIDE 14

PIF Audit : Findings

Common findings :

  • Lack of understanding/competency to prepare

the PIF

  • PIF not updated - Inconsistent with the

information declared during notification submission.

slide-15
SLIDE 15

PIF Audit : Findings

Common findings :

  • Incomplete PIF
  • insufficient data to support safety, quality

and claimed benefit

  • Label does not comply with the labeling

requirements :

  • incomplete ingredient list, absence of

warning statement, CNH name and address not stated on label, etc.

slide-16
SLIDE 16

PIF Audit : Findings

  • PIF audit for year 2012 :
  • Targeted number of PIF audit = 1098
  • Achieved number of PIF audit = 335 (30.5%) from 17
  • companies. Most of them are imported product.
slide-17
SLIDE 17

PIF Audit : Findings

  • Only 6 out of 17 companies enable to provide

complete PIF for the audit. The rest can be described further as in Figure below :

45% 55% 27% 100% 0% 20% 40% 60% 80% 100% 120% Part IV Part III Part II Part I

slide-18
SLIDE 18

PIF Audit : Current Approach

  • To broaden the PIF audit criteria such as :
  • By including more products from MNCs:
  • To evaluate the compliance level particularly related to

safety and claimed benefit.

  • Targeting more on ‘External Personal Care’ such as

antibacterial, antidandruff, etc. to evaluate the document to support such claim.

  • To increase no. of PIF audit.
slide-19
SLIDE 19

PIF Audit : Current Approach

  • More training programme to the cosmetic

industry.

  • To work more proactively with the ASEAN

member countries to facilitate the industry in the preparation of PIF.

slide-20
SLIDE 20

PIF Audit : Punitive Action

  • Current :

i) Warning letter and CNH to provide the

required document and corrective action within the given period.

  • The CNH in many case could not provide the required

document even at later time.

ii) Cancellation of Notification Note and product are ordered to be recalled from the market

  • Product with therapeutic claims or beyond the

cosmetic scope.

slide-21
SLIDE 21

PIF Audit : Punitive Action

By 2014:

i) Major Findings: Any major findings will cause in cancellation of notification note and product are ordered to be recalled from the market. The findings may include but not limited to:

  • Unable to provide PIF within the given period.
  • Incomplete PIF : particularly related to safety and quality

data.

  • Product with therapeutic claims or beyond the cosmetic

scope.

slide-22
SLIDE 22

PIF Audit : Punitive Action

By 2014:

i) Minor Findings: In this case, a warning letter with/without recall may be issued to the CNH for corrective action within the specified period. The finding may include but not limited to:

  • Insufficient claim substantiation which does not impact the

safety of consumer.

  • Incomplete label
slide-23
SLIDE 23

Thank you for your support !!!